Recent Updates
Recently added Catalysts
ELDN Positive Sentiment

Daniel Gilada’s Story

Key Takeaway: Daniel Gilada, diagnosed with type 1 diabetes at 18, has navigated significant health challenges while balancing his career as a cardiologist and family life. After years of fluctuating glucose levels and emotional struggles, he chose to participate in an islet transplant clinical trial. He emphasizes the importance of seeking help and support for those facing similar challenges.
Price reaction · baseline $4.045 (2024-11-14T17:09:00.000Z) · hit during market hours · 1 other ELDN headline(s) in the window, move may be shared
day 0 close · peak
+2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Daniel Gilada is now a practicing cardiologist.
  • He has taken proactive steps to manage his diabetes.
  • Daniel encourages others to seek help and support.

CONCERNS & RISKS

  • Daniel experienced significant health challenges due to diabetes.
  • He faced emotional struggles, including bouts of depression.
  • His condition impacted his daily responsibilities and family life.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
6.5%
average across 7 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
AT-1501
Phase 2 · Kidney Transplant Rejection

Full Press Release Details

Daniel Gilada

Daniel Gilada was leading a normal life for many years until he was diagnosed with acute onset type 1 diabetes at age 18.
As a high school athlete with aspirations to pursue a career in medicine, he was shocked by the implications this sudden diagnosis would have on his life. Now age 37, Daniel is a practicing cardiologist whose days are busy seeing patients and taking care of his family of three young children, with another on the way. Daniel fought to control his disease, but over the past several years his glucose levels were fluctuating dramatically making the responsibilities of his busy life more and more difficult to navigate.
“I was constantly planning work, the kids’ soccer practice, coaching, church, everything around my diabetes. Always asking myself, ‘Do I have my insulin? My cooler for the insulin? Will my sugar spike or crash today?’
“My diabetes was a constant burden and impacted every aspect of my day from the time I woke up to going to sleep. It was overwhelming.”
Daniel would have days where he felt awful and nauseous, and even with high blood sugar he would need to somehow get through long days of hospital rounds and 25 patient visits. In addition to health challenges, he has suffered bouts of depression – losing hope about his health and worrying about being alive and healthy for his young family. One day Daniel finally decided that he couldn’t keep living like this.
He researched his options and decided to participate in an investigator-led islet transplant clinical trial.
Daniel’s biggest advice for others living with type 1 diabetes is don’t be afraid to ask for help. “It is lonely and hard to do it on your own. It was hard for me to ask for help even though I was struggling. Surround yourself with people who care and who can help.”

Frequently Asked Questions

What was Daniel Gilada diagnosed with?

Daniel Gilada was diagnosed with acute onset type 1 diabetes at age 18.

How has diabetes affected Daniel's life?

Diabetes impacted Daniel's daily responsibilities and caused emotional struggles.

What advice does Daniel give to others with diabetes?

Daniel advises others to seek help and surround themselves with supportive people.

What clinical trial did Daniel participate in?

Daniel participated in an investigator-led islet transplant clinical trial.

Last updated: Nov 14, 2024